Overview

Alpha-Lipoic Acid in Breast Cancer Patients

Status:
Recruiting

Trial end date:
2019-10-01

Target enrollment:

Participant gender:

Summary

• Investigate the ability of alpha lipoic acid to counter act anthracycline associated cardiotoxicity and cumulative taxens-related PN in patients with breast cancer.

Phase:

N/A

Details

Lead Sponsor:

Damanhour University

Treatments:

Cyclophosphamide
Doxorubicin
Liposomal doxorubicin
Paclitaxel
Thioctic Acid